Jul
02
On the first day of the Tour de France, the one newspaper all cycling fans want to get their hands on is French sports daily, L’Equipe, but tomorrow it’s a very different publication, The Wall Street Journal, that carries the must-read story, apparently centered around further allegations from Floyd Landis of widespread use of performance enhancing substitutes within the sport of cycling.



